Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Grenier, , Pauline,
DOB: 03-MAY-1971 (Age: 54)
Gender: female
ID: 6776-872657-1 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 17-MAR-2025

Problem list

Condition Onset Date Status
Essential hypertension 25-Jan-2016 active
Metabolic syndrome X 25-Jan-2016 active
Prediabetes 20-Jan-2014 active

Medication list

Medication Since Form Dosage Reason
Lisinopril 10 mg oral tablet 2025-03-17 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 17-Mar-2025
SARS-CoV-2 mRNA vaccine 05-Jul-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 11-Feb-2019
Live attenuated Human alphaherpesvirus 3 only vaccine product 11-Feb-2019

Procedure History list

Procedure Date Reason
Pre-discharge assessment 22-Aug-2016 -
Discharge from skilled nursing facility (procedure) 22-Aug-2016 -
Professional / ancillary services care 21-Aug-2016 -
Nursing care/supplementary surveillance 21-Aug-2016 -
History AND physical examination 16-Aug-2016 -
Initial patient assessment 16-Aug-2016 -
Development of individualized plan of care 16-Aug-2016 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 25-Jan-2016 Essential hypertension (disorder)
  • Maintain blood pressure below 130/80 mmHg
  • Achieve at least 5% reduction in body weight
  • Engage in at least 150 minutes of moderate-intensity exercise per week
Diabetes self management plan 20-Jan-2014 Prediabetes
  • Achieve and maintain HbA1c below 5.7% through diabetes self-management.
  • Achieve and maintain a weight reduction of at least 5% from baseline to reduce diabetes risk.
  • Engage in at least 150 minutes of moderate-intensity physical activity per week.

Vital Signs

Vital Signs 2025-03-17 2024-03-11
Body Height 178.3 cm 178.3 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} 3 {score}
Body Weight 95.1 kg 96 kg
Body mass index (BMI) [Ratio] 29.9 kg/m2 30.2 kg/m2
Diastolic Blood Pressure 84 mm[Hg] 90 mm[Hg]
Systolic Blood Pressure 145 mm[Hg] 141 mm[Hg]
Heart rate 86 /min 61 /min
Respiratory rate 14 /min 15 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 17-MAR-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 99.8 H 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.3 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.5 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 103.5 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.7 22 - 29 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 20-Jan-2014